
Foresight sells Orthoview stake to Materialise
Foresight has sold its stake in Orthoview, a provider of orthopaedic templating for surgeons, to Belgium-based Materialise for £8.47m.
The sale will generate £1.35m for Foresight 3 VCT, with an initial consideration of £1.12m and the remainder to be released over the next two years.
Since Foresight's investment, the company has formed strategic partnerships with healthcare IT suppliers and invested in product development.
Previous funding
Foresight provided early-stage funding to Orthoview in 2003.
Company
Southampton-based Orthoview is a provider of digital prosthesis template libraries to orthopaedic surgeons. The company has an international client base of 10,000 surgeons and has strategic partnerships with GE Healthcare, Philips, Agfa and McKesson.
People
James Livingston, a director of Foresight, was responsible for the investment in Orthoview. John Chambers is CEO of Orthoview.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater